1. Home
  2. AVB vs GEHC Comparison

AVB vs GEHC Comparison

Compare AVB & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AVB

AvalonBay Communities Inc.

HOLD

Current Price

$187.55

Market Cap

27.8B

Sector

Real Estate

ML Signal

HOLD

Logo GE HealthCare Technologies Inc.

GEHC

GE HealthCare Technologies Inc.

HOLD

Current Price

$71.77

Market Cap

27.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVB
GEHC
Founded
1978
1892
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Computer Software: Prepackaged Software
Sector
Real Estate
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.8B
27.9B
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
AVB
GEHC
Price
$187.55
$71.77
Analyst Decision
Hold
Buy
Analyst Count
15
13
Target Price
$198.40
$88.38
AVG Volume (30 Days)
708.4K
5.5M
Earning Date
04-27-2026
04-29-2026
Dividend Yield
3.86%
0.24%
EPS Growth
N/A
4.84
EPS
3.43
0.85
Revenue
$3,040,725,000.00
$20,625,000,000.00
Revenue This Year
$4.04
$7.12
Revenue Next Year
$5.03
$4.45
P/E Ratio
$54.39
$82.72
Revenue Growth
4.36
4.84
52 Week Low
$160.10
$58.75
52 Week High
$198.63
$89.77

Technical Indicators

Market Signals
Indicator
AVB
GEHC
Relative Strength Index (RSI) 45.55 62.19
Support Level $174.68 $69.17
Resistance Level $188.44 $72.77
Average True Range (ATR) 3.36 1.94
MACD -0.54 0.77
Stochastic Oscillator 19.11 85.39

Price Performance

Historical Comparison
AVB
GEHC

About AVB AvalonBay Communities Inc.

AvalonBay Communities owns a portfolio of 296 apartment communities with more than 90,000 units and is developing 24 additional properties with approximately 8,600 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Share on Social Networks: